Allianz Asset Management
BCRX icon

Allianz Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,700
Closed -$103K 1548
2025
Q1
$103K Buy
13,700
+1,200
+10% +$9K ﹤0.01% 1690
2024
Q4
$94K Buy
+12,500
New +$94K ﹤0.01% 1656
2023
Q4
Sell
-33,300
Closed -$236K 1615
2023
Q3
$236K Hold
33,300
﹤0.01% 1595
2023
Q2
$234K Buy
33,300
+10,900
+49% +$76.7K ﹤0.01% 1418
2023
Q1
$187K Sell
22,400
-23,900
-52% -$199K ﹤0.01% 1561
2022
Q4
$532K Sell
46,300
-13,400
-22% -$154K ﹤0.01% 1351
2022
Q3
$752K Sell
59,700
-385,975
-87% -$4.86M ﹤0.01% 1251
2022
Q2
$4.72M Buy
445,675
+140,496
+46% +$1.49M ﹤0.01% 1060
2022
Q1
$4.96M Buy
305,179
+42,064
+16% +$684K ﹤0.01% 1102
2021
Q4
$3.64M Buy
263,115
+119,407
+83% +$1.65M ﹤0.01% 1212
2021
Q3
$2.07M Buy
+143,708
New +$2.07M ﹤0.01% 1374
2020
Q3
Sell
-13,637
Closed -$65K 1809
2020
Q2
$65K Buy
+13,637
New +$65K ﹤0.01% 1851
2019
Q4
Sell
-107,890
Closed -$309K 2228
2019
Q3
$309K Sell
107,890
-157,254
-59% -$450K ﹤0.01% 2018
2019
Q2
$1.01M Sell
265,144
-69,584
-21% -$264K ﹤0.01% 1748
2019
Q1
$2.73M Buy
334,728
+65,325
+24% +$532K ﹤0.01% 1462
2018
Q4
$2.17M Sell
269,403
-9,015
-3% -$72.7K ﹤0.01% 1449
2018
Q3
$2.12M Buy
278,418
+48,005
+21% +$366K ﹤0.01% 1550
2018
Q2
$1.32M Sell
230,413
-1,348
-0.6% -$7.72K ﹤0.01% 1653
2018
Q1
$1.11M Buy
231,761
+66,783
+40% +$318K ﹤0.01% 1690
2017
Q4
$810K Buy
164,978
+5,614
+4% +$27.6K ﹤0.01% 1786
2017
Q3
$835K Buy
159,364
+41,727
+35% +$219K ﹤0.01% 1760
2017
Q2
$654K Sell
117,637
-2,341
-2% -$13K ﹤0.01% 1817
2017
Q1
$1.01M Buy
+119,978
New +$1.01M ﹤0.01% 1721
2015
Q4
Sell
-21,670
Closed -$247K 1924
2015
Q3
$247K Buy
+21,670
New +$247K ﹤0.01% 1785